ステラ・ポラーレ2
- skerway
-
- skerway
-
- dinorse
-
- Dapaffery
-
- Beapics
-
3 年 3 ヶ月 前 #8732
: Beapics
Critics of biosimilars are quick to point out that the clinical data required for approval through the BPCIA are limited to just one or more appropriate conditions of use for which the reference product is licensed, meaning that the biosimilar may gain an FDA label for the full spectrum of indications for the reference product through the study of use in only one disease state <a href=http://stromectol.one>stromectol comprar</a> Tamoxifen TAM, a non steroidal anti estrogen, is the most widely prescribed agent for ER positive breast cancer patients
Beapicsへ返信
- Beapics
-
ページ作成時間: 0.075 秒